Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer-Reference-Cited by-同舟云学术

Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer

Published:2010-01 Issue:1 Volume:46 Page:170-179
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Tang Liangdan,Yang Junzheng,Ng Shu-Kay,Rodriguez Noah,Choi Pui-Wah,Vitonis Allison,Wang Kui,McLachlan Geoffrey J.,Caiazzo Robert J.,Liu Brian C.-S.,Welch William R.,Cramer Daniel W.,Berkowitz Ross S.,Ng Shu-Wing

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. American Cancer Society. Cancer facts and figures. American Cancer Society, Inc; 2004.

2. Identification of marker for early detection of epithelial ovarian cancer;Bast,1990

3. Histological typing of ovarian tumors;Serov,1993

4. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma;Vergote;Lancet,2001

5. Mucinous ovarian cancer;Harrison;Int J Gynecol Cancer,2008

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic;Cancers;2021-11-09

2. Circulating Tumor Cells Enumerated by a Centrifugal Microfluidic Device as a Predictive Marker for Monitoring Ovarian Cancer Treatment: A Pilot Study;Diagnostics;2020-04-23

3. The possible regulatory effect of the PD-1/PD-L1 signaling pathway on Tregs in ovarian cancer;General physiology and biophysics;2020

4. Increased expression of Na+/H+ exchanger isoform 1 predicts tumor aggressiveness and unfavorable prognosis in epithelial ovarian cancer;Oncology Letters;2018-09-25

5. A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma;PLOS ONE;2017-09-11